- Featured Product
- KD/KO Validated
Cytokeratin 19 Polyclonal antibody
Cytokeratin 19 Polyclonal Antibody for FC, IF, IHC, WB, ELISA
Cat no : 14965-1-AP
Validation Data Gallery
|Positive WB detected in||MCF7 cells, HeLa cells, HepG2 cells, BxPC-3 cells|
|Positive IHC detected in||human colon tissue, human lung cancer tissue, human liver cancer tissue, human cervical cancer tissue, rat colon tissue, mouse colon tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive IF detected in||HeLa cells, A431 cells|
|Positive FC detected in||MCF-7 cells|
|Western Blot (WB)||WB : 1:500-1:3000|
|Immunohistochemistry (IHC)||IHC : 1:1000-1:6400|
|Immunofluorescence (IF)||IF : 1:200-1:800|
|Sample-dependent, check data in validation data gallery|
14965-1-AP targets Cytokeratin 19 in WB, IHC, IF, FC, ELISA applications and shows reactivity with human, mouse, rat samples.
|Tested Reactivity||human, mouse, rat|
|Cited Reactivity||human, mouse, rat, monkey|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Cytokeratin 19 fusion protein Ag6830|
|Full Name||keratin 19|
|Calculated molecular weight||44 kDa|
|Observed molecular weight||40 kDa, 46 kDa|
|GenBank accession number||BC002539|
|Gene ID (NCBI)||3880|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
Keratins are a large family of proteins that form the intermediate filament cytoskeleton of epithelial cells, which are classified into two major sequence types. Type I keratins are a group of acidic intermediate filament proteins, including K9-K23, and the hair keratins Ha1-Ha8. Type II keratins are the basic or neutral courterparts to the acidic type I keratins, including K1-K8, and the hair keratins, Hb1-Hb6. KRT19, one of type I keratins, is specifically expressed in the periderm, the transiently superficial layer that envelopes the developing epidermis. Due to its high sensitivity, KRT19 is the most used marker for detection of tumor cells disseminated in lymph nodes, peripheral blood, and bone marrow of breast cancer patients. This antibody, generated against full length KRT19 protein, also recognizes KRT17, another type I keratin homologous to KRT19.
|Product Specific Protocols|
|WB protocol for Cytokeratin 19 antibody 14965-1-AP||Download protocol|
|IHC protocol for Cytokeratin 19 antibody 14965-1-AP||Download protocol|
|IF protocol for Cytokeratin 19 antibody 14965-1-AP||Download protocol|
|FC protocol for Cytokeratin 19 antibody 14965-1-AP||Download protocol|
|Click here to view our Standard Protocols|
ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice.
Cholestasis-induced adaptive remodeling of interlobular bile ducts.
In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer.
Galunisertib modifies the liver fibrotic composition in the Abcb4Ko mouse model.
Front Cell Dev Biol
Volumetric imaging reveals VEGF-C-dependent formation of hepatic lymph vessels in mice
Biochim Biophys Acta Mol Basis Dis
The zonula occludens protein family regulates the hepatic barrier system in the murine liver.